<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02912195</url>
  </required_header>
  <id_info>
    <org_study_id>00001</org_study_id>
    <nct_id>NCT02912195</nct_id>
  </id_info>
  <brief_title>Intravenous Lidocaine Versus Morphine for Severe Pain in the ED</brief_title>
  <official_title>Intravenous Lidocaine Versus Provider Chosen Dose of Morphine for the Treatment of Severe Pain in the Emergency Department: An Open-label Randomized Controlled Pilot Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Alameda Health System</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Alameda Health System</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Objective: Evaluate the analgesic efficacy of intravenous (IV) lidocaine versus provider
      chosen dose of IV morphine for the treatment of severe pain in the emergency department.

      Study design: Open-label, randomized controlled pilot study.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Objective: The purpose of this pilot study is to determine the analgesic efficacy of
      intravenous lidocaine versus morphine for the treatment of severe pain in the emergency
      department (ED).

      Study design: Open-label, randomized, controlled pilot trial. Participants: Investigators and
      research assistants will recruit patients ≥18 years old with severe pain (NRS ≥7) and an
      anticipated stay in the emergency department ≥1 hour. A sample size calculation was performed
      and 32 patients will be enrolled.

      Intervention: After a trained research assistant obtains written informed consent, eligible
      participants will be randomized to the intravenous lidocaine or morphine arms of the study.
      In the intravenous lidocaine arm, patients will receive IV lidocaine (75 mg if &lt;50kg, 100 mg
      if 50 - 100 kg, and 150 mg if &gt;100 kg) over 10 minutes in a 100 mL normal saline minibag
      followed by a 50 minute IV lidocaine drip (75 mg if &lt;50kg, 100 mg if 50 - 100 kg, and 150 mg
      if &gt;100 kg). In the morphine arm, the ED provider will choose an appropriate dose of morphine
      for the patient. At 20 and 40 minutes, the participants will be asked &quot;Would you like
      additional pain medication?&quot;. Participants responding in the affirmative will receive
      morphine 4 mg IV.

      Data collection: The trained research assistant will collect data on the patients' pain
      scores, side effects, and rescue morphine.

      Statistical analysis: Investigators will perform descriptive statistics and compare pain
      scores and pain relief at each time point with unpaired t-tests.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>March 2016</start_date>
  <completion_date type="Actual">September 2016</completion_date>
  <primary_completion_date type="Actual">September 2016</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pain Score (NRS 0-10)</measure>
    <time_frame>At 60 minutes</time_frame>
    <description>Pain score is rated on the Numeric Rating Scale from 0-10. 0 represents no pain and 10 represents the worst possible pain.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pain Score (NRS 0-10)</measure>
    <time_frame>At 10 minutes</time_frame>
    <description>Pain score recorded on the numeric rating scale 0-10.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain Score (NRS 0-10)</measure>
    <time_frame>At 20 minutes</time_frame>
    <description>Pain score recorded on the numeric rating scale 0-10. 0 represents no pain and 10 represents the worst pain.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain Score (NRS 0-10)</measure>
    <time_frame>At 30 minutes</time_frame>
    <description>Pain score recorded on the numeric rating scale 0-10.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain Score (NRS 0-10)</measure>
    <time_frame>At 40 minutes</time_frame>
    <description>Pain score recorded on the numeric rating scale 0-10.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain Score (NRS 0-10)</measure>
    <time_frame>At 50 minutes</time_frame>
    <description>Pain score recorded on the numeric rating scale 0-10.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain Relief at 10 Minutes Compared to Baseline.</measure>
    <time_frame>At 10 minutes</time_frame>
    <description>Pain NRS at 0 minutes minus pain NRS at 10 minutes</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain Relief at 20 Minutes Compared to Baseline.</measure>
    <time_frame>at 20 minutes</time_frame>
    <description>Pain numeric rating scale (NRS) at 0 minutes minus pain NRS at 20 minutes. NRS is a scale ranging from 0, no pain, to 10 worst pain.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain Relief at 30 Minutes Compared to Baseline.</measure>
    <time_frame>at 30 minutes</time_frame>
    <description>Pain numeric rating scale (NRS) at 0 minutes minus pain NRS at 30 minutes NRS is a scale ranging from 0, no pain, to 10 worst pain.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain Relief at 40 Minutes Compared to Baseline.</measure>
    <time_frame>At 40 minutes</time_frame>
    <description>Pain numeric rating scale (NRS) at 0 minutes minus pain NRS at 40 minutes. NRS is a scale ranging from 0, no pain, to 10 worst pain.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain Relief at 50 Minutes Compared to Baseline.</measure>
    <time_frame>At 50 minutes</time_frame>
    <description>Pain numeric rating scale (NRS) at 0 minutes minus pain NRS at 50 minutes. NRS is a scale ranging from 0, no pain, to 10 worst pain.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain Relief at 60 Minutes Compared to Baseline.</measure>
    <time_frame>At 60 minutes</time_frame>
    <description>Pain numeric rating scale (NRS) at 0 minutes minus pain NRS at 60 minutes. NRS is a scale ranging from 0, no pain, to 10 worst pain.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants Requiring Rescue Medications</measure>
    <time_frame>At 20 and 40 minutes</time_frame>
    <description>The percentage of patients requiring rescue IV morphine at 20 and 40 minutes</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient Satisfaction</measure>
    <time_frame>60 minutes</time_frame>
    <description>The proportion of patients saying, &quot;Yes&quot; to &quot;Would you have this pain medication again for similar pain?&quot;</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants Reporting Adverse Events</measure>
    <time_frame>0-60 minutes</time_frame>
    <description>Participants will be observed for the following adverse events and side effects: seizure, bradyarrhythmias, hyper or hypotension, perioral numbness, tinnitus, metallic taste, other, hypotension, hypoxia, nausea, vomiting, itching, or other side effects. Participants have the opportunity to report other side effects during the study</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">32</enrollment>
  <condition>Pain</condition>
  <arm_group>
    <arm_group_label>Intravenous lidocaine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants will receive IV lidocaine (75 mg if &lt;50kg, 100 mg if 50 - 100 kg, and 150 mg if &gt;100 kg) over 10 minutes in a 100 mL normal saline minibag followed by a 50 minute IV lidocaine drip (75 mg if &lt;50kg, 100 mg if 50 - 100 kg, and 150 mg if &gt;100 kg) in a 100 mL normal saline minibag.
At 20 and 40 minutes, participants can elect to receive morphine 4mg IV as a rescue analgesic.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Morphine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>ED provider will choose an appropriate dose of intravenous morphine for the patient.
At 20 and 40 minutes, participants can elect to receive morphine 4mg IV as a rescue analgesic.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Intravenous lidocaine</intervention_name>
    <description>Intravenous lidocaine drip over 10 minutes followed by intravenous lidocaine drip over 50 minutes</description>
    <arm_group_label>Intravenous lidocaine</arm_group_label>
    <other_name>lignocaine</other_name>
    <other_name>Xylocaine</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Intravenous morphine</intervention_name>
    <description>Emergency department provider chooses appropriate dose of intravenous morphine</description>
    <arm_group_label>Morphine</arm_group_label>
    <other_name>duramorph</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Subject has severe pain (NRS ≥7)

          -  Subject has anticipated ED stay of ≥1 hour

        Exclusion Criteria:

          -  High acuity trauma patients

          -  Patients deemed to critically ill by ED provider

          -  Active psychosis

          -  Pregnancy

          -  History of heart block or bradycardia

          -  Allergy to lidocaine or amide type local anesthetic

          -  History of seizures
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Andrew Herring, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Alameda Health System, Highland Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Alameda Health System, Highland Hospital</name>
      <address>
        <city>Oakland</city>
        <state>California</state>
        <zip>94602</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>September 20, 2016</study_first_submitted>
  <study_first_submitted_qc>September 22, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 23, 2016</study_first_posted>
  <results_first_submitted>June 26, 2018</results_first_submitted>
  <results_first_submitted_qc>March 24, 2020</results_first_submitted_qc>
  <results_first_posted type="Actual">April 6, 2020</results_first_posted>
  <last_update_submitted>March 24, 2020</last_update_submitted>
  <last_update_submitted_qc>March 24, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">April 6, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Alameda Health System</investigator_affiliation>
    <investigator_full_name>Eben Clattenburg</investigator_full_name>
    <investigator_title>Principle Investigator</investigator_title>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lidocaine</mesh_term>
    <mesh_term>Morphine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Intravenous Lidocaine</title>
          <description>Participants will receive IV lidocaine (75 mg if &lt;50kg, 100 mg if 50 – 100 kg, and 150 mg if &gt;100 kg) over 10 minutes in a 100 mL normal saline minibag followed by a 50 minute IV lidocaine drip (75 mg if &lt;50kg, 100 mg if 50 – 100 kg, and 150 mg if &gt;100 kg) in a 100 mL normal saline minibag.
At 20 and 40 minutes, participants can elect to receive morphine 4mg IV as a rescue analgesic.
Intravenous lidocaine: Intravenous lidocaine drip over 10 minutes followed by intravenous lidocaine drip over 50 minutes</description>
        </group>
        <group group_id="P2">
          <title>Morphine</title>
          <description>ED provider will choose an appropriate dose of intravenous morphine for the patient.
At 20 and 40 minutes, participants can elect to receive morphine 4mg IV as a rescue analgesic.
Intravenous morphine: Emergency department provider chooses appropriate dose of intravenous morphine</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="16"/>
                <participants group_id="P2" count="16"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="16"/>
                <participants group_id="P2" count="16"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Intravenous Lidocaine</title>
          <description>Participants will receive IV lidocaine (75 mg if &lt;50kg, 100 mg if 50 – 100 kg, and 150 mg if &gt;100 kg) over 10 minutes in a 100 mL normal saline minibag followed by a 50 minute IV lidocaine drip (75 mg if &lt;50kg, 100 mg if 50 – 100 kg, and 150 mg if &gt;100 kg) in a 100 mL normal saline minibag.
At 20 and 40 minutes, participants can elect to receive morphine 4mg IV as a rescue analgesic.
Intravenous lidocaine: Intravenous lidocaine drip over 10 minutes followed by intravenous lidocaine drip over 50 minutes</description>
        </group>
        <group group_id="B2">
          <title>Morphine</title>
          <description>ED provider will choose an appropriate dose of intravenous morphine for the patient.
At 20 and 40 minutes, participants can elect to receive morphine 4mg IV as a rescue analgesic.
Intravenous morphine: Emergency department provider chooses appropriate dose of intravenous morphine</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="16"/>
            <count group_id="B2" value="16"/>
            <count group_id="B3" value="32"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="16"/>
                    <count group_id="B2" value="16"/>
                    <count group_id="B3" value="32"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="50" lower_limit="36.5" upper_limit="59.5"/>
                    <measurement group_id="B2" value="45.5" lower_limit="34" upper_limit="59.5"/>
                    <measurement group_id="B3" value="46" lower_limit="36" upper_limit="59.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="16"/>
                    <count group_id="B2" value="16"/>
                    <count group_id="B3" value="32"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="8"/>
                    <measurement group_id="B2" value="9"/>
                    <measurement group_id="B3" value="17"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="8"/>
                    <measurement group_id="B2" value="7"/>
                    <measurement group_id="B3" value="15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race and Ethnicity Not Collected</title>
          <population>Race and Ethnicity were not collected from any participant.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="0"/>
                    <count group_id="B2" value="0"/>
                    <count group_id="B3" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Pain Score (NRS 0-10)</title>
        <description>Pain score is rated on the Numeric Rating Scale from 0-10. 0 represents no pain and 10 represents the worst possible pain.</description>
        <time_frame>At 60 minutes</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Intravenous Lidocaine</title>
            <description>Participants will receive IV lidocaine (75 mg if &lt;50kg, 100 mg if 50 – 100 kg, and 150 mg if &gt;100 kg) over 10 minutes in a 100 mL normal saline minibag followed by a 50 minute IV lidocaine drip (75 mg if &lt;50kg, 100 mg if 50 – 100 kg, and 150 mg if &gt;100 kg) in a 100 mL normal saline minibag.
At 20 and 40 minutes, participants can elect to receive morphine 4mg IV as a rescue analgesic.
Intravenous lidocaine: Intravenous lidocaine drip over 10 minutes followed by intravenous lidocaine drip over 50 minutes</description>
          </group>
          <group group_id="O2">
            <title>Morphine</title>
            <description>ED provider will choose an appropriate dose of intravenous morphine for the patient.
At 20 and 40 minutes, participants can elect to receive morphine 4mg IV as a rescue analgesic.
Intravenous morphine: Emergency department provider chooses appropriate dose of intravenous morphine</description>
          </group>
        </group_list>
        <measure>
          <title>Pain Score (NRS 0-10)</title>
          <description>Pain score is rated on the Numeric Rating Scale from 0-10. 0 represents no pain and 10 represents the worst possible pain.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="16"/>
                <count group_id="O2" value="16"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.1" lower_limit="3.3" upper_limit="6.8"/>
                    <measurement group_id="O2" value="4.2" lower_limit="3.0" upper_limit="5.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Pain Score (NRS 0-10)</title>
        <description>Pain score recorded on the numeric rating scale 0-10.</description>
        <time_frame>At 10 minutes</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Intravenous Lidocaine</title>
            <description>Participants will receive IV lidocaine (75 mg if &lt;50kg, 100 mg if 50 – 100 kg, and 150 mg if &gt;100 kg) over 10 minutes in a 100 mL normal saline minibag followed by a 50 minute IV lidocaine drip (75 mg if &lt;50kg, 100 mg if 50 – 100 kg, and 150 mg if &gt;100 kg) in a 100 mL normal saline minibag.
At 20 and 40 minutes, participants can elect to receive morphine 4mg IV as a rescue analgesic.
Intravenous lidocaine: Intravenous lidocaine drip over 10 minutes followed by intravenous lidocaine drip over 50 minutes</description>
          </group>
          <group group_id="O2">
            <title>Morphine</title>
            <description>ED provider will choose an appropriate dose of intravenous morphine for the patient.
At 20 and 40 minutes, participants can elect to receive morphine 4mg IV as a rescue analgesic.
Intravenous morphine: Emergency department provider chooses appropriate dose of intravenous morphine</description>
          </group>
        </group_list>
        <measure>
          <title>Pain Score (NRS 0-10)</title>
          <description>Pain score recorded on the numeric rating scale 0-10.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="16"/>
                <count group_id="O2" value="16"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.1" lower_limit="7.1" upper_limit="9.0"/>
                    <measurement group_id="O2" value="8.9" lower_limit="8.3" upper_limit="9.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Pain Score (NRS 0-10)</title>
        <description>Pain score recorded on the numeric rating scale 0-10. 0 represents no pain and 10 represents the worst pain.</description>
        <time_frame>At 20 minutes</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Intravenous Lidocaine</title>
            <description>Participants will receive IV lidocaine (75 mg if &lt;50kg, 100 mg if 50 – 100 kg, and 150 mg if &gt;100 kg) over 10 minutes in a 100 mL normal saline minibag followed by a 50 minute IV lidocaine drip (75 mg if &lt;50kg, 100 mg if 50 – 100 kg, and 150 mg if &gt;100 kg) in a 100 mL normal saline minibag.
At 20 and 40 minutes, participants can elect to receive morphine 4mg IV as a rescue analgesic.
Intravenous lidocaine: Intravenous lidocaine drip over 10 minutes followed by intravenous lidocaine drip over 50 minutes</description>
          </group>
          <group group_id="O2">
            <title>Morphine</title>
            <description>ED provider will choose an appropriate dose of intravenous morphine for the patient.
At 20 and 40 minutes, participants can elect to receive morphine 4mg IV as a rescue analgesic.
Intravenous morphine: Emergency department provider chooses appropriate dose of intravenous morphine</description>
          </group>
        </group_list>
        <measure>
          <title>Pain Score (NRS 0-10)</title>
          <description>Pain score recorded on the numeric rating scale 0-10. 0 represents no pain and 10 represents the worst pain.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="16"/>
                <count group_id="O2" value="16"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7.4" lower_limit="6.3" upper_limit="8.4"/>
                    <measurement group_id="O2" value="6.2" lower_limit="4.6" upper_limit="7.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Pain Score (NRS 0-10)</title>
        <description>Pain score recorded on the numeric rating scale 0-10.</description>
        <time_frame>At 30 minutes</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Intravenous Lidocaine</title>
            <description>Participants will receive IV lidocaine (75 mg if &lt;50kg, 100 mg if 50 – 100 kg, and 150 mg if &gt;100 kg) over 10 minutes in a 100 mL normal saline minibag followed by a 50 minute IV lidocaine drip (75 mg if &lt;50kg, 100 mg if 50 – 100 kg, and 150 mg if &gt;100 kg) in a 100 mL normal saline minibag.
At 20 and 40 minutes, participants can elect to receive morphine 4mg IV as a rescue analgesic.
Intravenous lidocaine: Intravenous lidocaine drip over 10 minutes followed by intravenous lidocaine drip over 50 minutes</description>
          </group>
          <group group_id="O2">
            <title>Morphine</title>
            <description>ED provider will choose an appropriate dose of intravenous morphine for the patient.
At 20 and 40 minutes, participants can elect to receive morphine 4mg IV as a rescue analgesic.
Intravenous morphine: Emergency department provider chooses appropriate dose of intravenous morphine</description>
          </group>
        </group_list>
        <measure>
          <title>Pain Score (NRS 0-10)</title>
          <description>Pain score recorded on the numeric rating scale 0-10.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="16"/>
                <count group_id="O2" value="16"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7.0" lower_limit="5.9" upper_limit="8.1"/>
                    <measurement group_id="O2" value="5.6" lower_limit="4.0" upper_limit="7.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Pain Score (NRS 0-10)</title>
        <description>Pain score recorded on the numeric rating scale 0-10.</description>
        <time_frame>At 40 minutes</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Intravenous Lidocaine</title>
            <description>Participants will receive IV lidocaine (75 mg if &lt;50kg, 100 mg if 50 – 100 kg, and 150 mg if &gt;100 kg) over 10 minutes in a 100 mL normal saline minibag followed by a 50 minute IV lidocaine drip (75 mg if &lt;50kg, 100 mg if 50 – 100 kg, and 150 mg if &gt;100 kg) in a 100 mL normal saline minibag.
At 20 and 40 minutes, participants can elect to receive morphine 4mg IV as a rescue analgesic.
Intravenous lidocaine: Intravenous lidocaine drip over 10 minutes followed by intravenous lidocaine drip over 50 minutes</description>
          </group>
          <group group_id="O2">
            <title>Morphine</title>
            <description>ED provider will choose an appropriate dose of intravenous morphine for the patient.
At 20 and 40 minutes, participants can elect to receive morphine 4mg IV as a rescue analgesic.
Intravenous morphine: Emergency department provider chooses appropriate dose of intravenous morphine</description>
          </group>
        </group_list>
        <measure>
          <title>Pain Score (NRS 0-10)</title>
          <description>Pain score recorded on the numeric rating scale 0-10.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="16"/>
                <count group_id="O2" value="16"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.3" lower_limit="5.0" upper_limit="7.5"/>
                    <measurement group_id="O2" value="4.7" lower_limit="3.2" upper_limit="6.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Pain Score (NRS 0-10)</title>
        <description>Pain score recorded on the numeric rating scale 0-10.</description>
        <time_frame>At 50 minutes</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Intravenous Lidocaine</title>
            <description>Participants will receive IV lidocaine (75 mg if &lt;50kg, 100 mg if 50 – 100 kg, and 150 mg if &gt;100 kg) over 10 minutes in a 100 mL normal saline minibag followed by a 50 minute IV lidocaine drip (75 mg if &lt;50kg, 100 mg if 50 – 100 kg, and 150 mg if &gt;100 kg) in a 100 mL normal saline minibag.
At 20 and 40 minutes, participants can elect to receive morphine 4mg IV as a rescue analgesic.
Intravenous lidocaine: Intravenous lidocaine drip over 10 minutes followed by intravenous lidocaine drip over 50 minutes</description>
          </group>
          <group group_id="O2">
            <title>Morphine</title>
            <description>ED provider will choose an appropriate dose of intravenous morphine for the patient.
At 20 and 40 minutes, participants can elect to receive morphine 4mg IV as a rescue analgesic.
Intravenous morphine: Emergency department provider chooses appropriate dose of intravenous morphine</description>
          </group>
        </group_list>
        <measure>
          <title>Pain Score (NRS 0-10)</title>
          <description>Pain score recorded on the numeric rating scale 0-10.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="16"/>
                <count group_id="O2" value="16"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.6" lower_limit="4.1" upper_limit="7.1"/>
                    <measurement group_id="O2" value="4.6" lower_limit="3.1" upper_limit="6.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Pain Relief at 10 Minutes Compared to Baseline.</title>
        <description>Pain NRS at 0 minutes minus pain NRS at 10 minutes</description>
        <time_frame>At 10 minutes</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Intravenous Lidocaine</title>
            <description>Participants will receive IV lidocaine (75 mg if &lt;50kg, 100 mg if 50 – 100 kg, and 150 mg if &gt;100 kg) over 10 minutes in a 100 mL normal saline minibag followed by a 50 minute IV lidocaine drip (75 mg if &lt;50kg, 100 mg if 50 – 100 kg, and 150 mg if &gt;100 kg) in a 100 mL normal saline minibag.
At 20 and 40 minutes, participants can elect to receive morphine 4mg IV as a rescue analgesic.
Intravenous lidocaine: Intravenous lidocaine drip over 10 minutes followed by intravenous lidocaine drip over 50 minutes</description>
          </group>
          <group group_id="O2">
            <title>Morphine</title>
            <description>ED provider will choose an appropriate dose of intravenous morphine for the patient.
At 20 and 40 minutes, participants can elect to receive morphine 4mg IV as a rescue analgesic.
Intravenous morphine: Emergency department provider chooses appropriate dose of intravenous morphine</description>
          </group>
        </group_list>
        <measure>
          <title>Pain Relief at 10 Minutes Compared to Baseline.</title>
          <description>Pain NRS at 0 minutes minus pain NRS at 10 minutes</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="16"/>
                <count group_id="O2" value="16"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.1" lower_limit="0.5" upper_limit="1.8"/>
                    <measurement group_id="O2" value="2.0" lower_limit="0.9" upper_limit="3.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Pain Relief at 20 Minutes Compared to Baseline.</title>
        <description>Pain numeric rating scale (NRS) at 0 minutes minus pain NRS at 20 minutes. NRS is a scale ranging from 0, no pain, to 10 worst pain.</description>
        <time_frame>at 20 minutes</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Intravenous Lidocaine</title>
            <description>Participants will receive IV lidocaine (75 mg if &lt;50kg, 100 mg if 50 – 100 kg, and 150 mg if &gt;100 kg) over 10 minutes in a 100 mL normal saline minibag followed by a 50 minute IV lidocaine drip (75 mg if &lt;50kg, 100 mg if 50 – 100 kg, and 150 mg if &gt;100 kg) in a 100 mL normal saline minibag.
At 20 and 40 minutes, participants can elect to receive morphine 4mg IV as a rescue analgesic.
Intravenous lidocaine: Intravenous lidocaine drip over 10 minutes followed by intravenous lidocaine drip over 50 minutes</description>
          </group>
          <group group_id="O2">
            <title>Morphine</title>
            <description>ED provider will choose an appropriate dose of intravenous morphine for the patient.
At 20 and 40 minutes, participants can elect to receive morphine 4mg IV as a rescue analgesic.
Intravenous morphine: Emergency department provider chooses appropriate dose of intravenous morphine</description>
          </group>
        </group_list>
        <measure>
          <title>Pain Relief at 20 Minutes Compared to Baseline.</title>
          <description>Pain numeric rating scale (NRS) at 0 minutes minus pain NRS at 20 minutes. NRS is a scale ranging from 0, no pain, to 10 worst pain.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="16"/>
                <count group_id="O2" value="16"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.8" lower_limit="1.1" upper_limit="2.5"/>
                    <measurement group_id="O2" value="2.8" lower_limit="1.4" upper_limit="4.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Pain Relief at 30 Minutes Compared to Baseline.</title>
        <description>Pain numeric rating scale (NRS) at 0 minutes minus pain NRS at 30 minutes NRS is a scale ranging from 0, no pain, to 10 worst pain.</description>
        <time_frame>at 30 minutes</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Intravenous Lidocaine</title>
            <description>Participants will receive IV lidocaine (75 mg if &lt;50kg, 100 mg if 50 – 100 kg, and 150 mg if &gt;100 kg) over 10 minutes in a 100 mL normal saline minibag followed by a 50 minute IV lidocaine drip (75 mg if &lt;50kg, 100 mg if 50 – 100 kg, and 150 mg if &gt;100 kg) in a 100 mL normal saline minibag.
At 20 and 40 minutes, participants can elect to receive morphine 4mg IV as a rescue analgesic.
Intravenous lidocaine: Intravenous lidocaine drip over 10 minutes followed by intravenous lidocaine drip over 50 minutes</description>
          </group>
          <group group_id="O2">
            <title>Morphine</title>
            <description>ED provider will choose an appropriate dose of intravenous morphine for the patient.
At 20 and 40 minutes, participants can elect to receive morphine 4mg IV as a rescue analgesic.
Intravenous morphine: Emergency department provider chooses appropriate dose of intravenous morphine</description>
          </group>
        </group_list>
        <measure>
          <title>Pain Relief at 30 Minutes Compared to Baseline.</title>
          <description>Pain numeric rating scale (NRS) at 0 minutes minus pain NRS at 30 minutes NRS is a scale ranging from 0, no pain, to 10 worst pain.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="16"/>
                <count group_id="O2" value="16"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.2" lower_limit="1.4" upper_limit="3.0"/>
                    <measurement group_id="O2" value="3.4" lower_limit="1.9" upper_limit="4.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Pain Relief at 40 Minutes Compared to Baseline.</title>
        <description>Pain numeric rating scale (NRS) at 0 minutes minus pain NRS at 40 minutes. NRS is a scale ranging from 0, no pain, to 10 worst pain.</description>
        <time_frame>At 40 minutes</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Intravenous Lidocaine</title>
            <description>Participants will receive IV lidocaine (75 mg if &lt;50kg, 100 mg if 50 – 100 kg, and 150 mg if &gt;100 kg) over 10 minutes in a 100 mL normal saline minibag followed by a 50 minute IV lidocaine drip (75 mg if &lt;50kg, 100 mg if 50 – 100 kg, and 150 mg if &gt;100 kg) in a 100 mL normal saline minibag.
At 20 and 40 minutes, participants can elect to receive morphine 4mg IV as a rescue analgesic.
Intravenous lidocaine: Intravenous lidocaine drip over 10 minutes followed by intravenous lidocaine drip over 50 minutes</description>
          </group>
          <group group_id="O2">
            <title>Morphine</title>
            <description>ED provider will choose an appropriate dose of intravenous morphine for the patient.
At 20 and 40 minutes, participants can elect to receive morphine 4mg IV as a rescue analgesic.
Intravenous morphine: Emergency department provider chooses appropriate dose of intravenous morphine</description>
          </group>
        </group_list>
        <measure>
          <title>Pain Relief at 40 Minutes Compared to Baseline.</title>
          <description>Pain numeric rating scale (NRS) at 0 minutes minus pain NRS at 40 minutes. NRS is a scale ranging from 0, no pain, to 10 worst pain.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="16"/>
                <count group_id="O2" value="16"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.9" lower_limit="1.7" upper_limit="4.1"/>
                    <measurement group_id="O2" value="4.2" lower_limit="2.9" upper_limit="5.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Pain Relief at 50 Minutes Compared to Baseline.</title>
        <description>Pain numeric rating scale (NRS) at 0 minutes minus pain NRS at 50 minutes. NRS is a scale ranging from 0, no pain, to 10 worst pain.</description>
        <time_frame>At 50 minutes</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Intravenous Lidocaine</title>
            <description>Participants will receive IV lidocaine (75 mg if &lt;50kg, 100 mg if 50 – 100 kg, and 150 mg if &gt;100 kg) over 10 minutes in a 100 mL normal saline minibag followed by a 50 minute IV lidocaine drip (75 mg if &lt;50kg, 100 mg if 50 – 100 kg, and 150 mg if &gt;100 kg) in a 100 mL normal saline minibag.
At 20 and 40 minutes, participants can elect to receive morphine 4mg IV as a rescue analgesic.
Intravenous lidocaine: Intravenous lidocaine drip over 10 minutes followed by intravenous lidocaine drip over 50 minutes</description>
          </group>
          <group group_id="O2">
            <title>Morphine</title>
            <description>ED provider will choose an appropriate dose of intravenous morphine for the patient.
At 20 and 40 minutes, participants can elect to receive morphine 4mg IV as a rescue analgesic.
Intravenous morphine: Emergency department provider chooses appropriate dose of intravenous morphine</description>
          </group>
        </group_list>
        <measure>
          <title>Pain Relief at 50 Minutes Compared to Baseline.</title>
          <description>Pain numeric rating scale (NRS) at 0 minutes minus pain NRS at 50 minutes. NRS is a scale ranging from 0, no pain, to 10 worst pain.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="16"/>
                <count group_id="O2" value="16"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.6" lower_limit="2.2" upper_limit="5.0"/>
                    <measurement group_id="O2" value="4.4" lower_limit="3.2" upper_limit="5.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Pain Relief at 60 Minutes Compared to Baseline.</title>
        <description>Pain numeric rating scale (NRS) at 0 minutes minus pain NRS at 60 minutes. NRS is a scale ranging from 0, no pain, to 10 worst pain.</description>
        <time_frame>At 60 minutes</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Intravenous Lidocaine</title>
            <description>Participants will receive IV lidocaine (75 mg if &lt;50kg, 100 mg if 50 – 100 kg, and 150 mg if &gt;100 kg) over 10 minutes in a 100 mL normal saline minibag followed by a 50 minute IV lidocaine drip (75 mg if &lt;50kg, 100 mg if 50 – 100 kg, and 150 mg if &gt;100 kg) in a 100 mL normal saline minibag.
At 20 and 40 minutes, participants can elect to receive morphine 4mg IV as a rescue analgesic.
Intravenous lidocaine: Intravenous lidocaine drip over 10 minutes followed by intravenous lidocaine drip over 50 minutes</description>
          </group>
          <group group_id="O2">
            <title>Morphine</title>
            <description>ED provider will choose an appropriate dose of intravenous morphine for the patient.
At 20 and 40 minutes, participants can elect to receive morphine 4mg IV as a rescue analgesic.
Intravenous morphine: Emergency department provider chooses appropriate dose of intravenous morphine</description>
          </group>
        </group_list>
        <measure>
          <title>Pain Relief at 60 Minutes Compared to Baseline.</title>
          <description>Pain numeric rating scale (NRS) at 0 minutes minus pain NRS at 60 minutes. NRS is a scale ranging from 0, no pain, to 10 worst pain.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="16"/>
                <count group_id="O2" value="16"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.1" lower_limit="2.6" upper_limit="5.7"/>
                    <measurement group_id="O2" value="4.8" lower_limit="3.7" upper_limit="5.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants Requiring Rescue Medications</title>
        <description>The percentage of patients requiring rescue IV morphine at 20 and 40 minutes</description>
        <time_frame>At 20 and 40 minutes</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Intravenous Lidocaine</title>
            <description>Participants will receive IV lidocaine (75 mg if &lt;50kg, 100 mg if 50 – 100 kg, and 150 mg if &gt;100 kg) over 10 minutes in a 100 mL normal saline minibag followed by a 50 minute IV lidocaine drip (75 mg if &lt;50kg, 100 mg if 50 – 100 kg, and 150 mg if &gt;100 kg) in a 100 mL normal saline minibag.
At 20 and 40 minutes, participants can elect to receive morphine 4mg IV as a rescue analgesic.
Intravenous lidocaine: Intravenous lidocaine drip over 10 minutes followed by intravenous lidocaine drip over 50 minutes</description>
          </group>
          <group group_id="O2">
            <title>Morphine</title>
            <description>ED provider will choose an appropriate dose of intravenous morphine for the patient.
At 20 and 40 minutes, participants can elect to receive morphine 4mg IV as a rescue analgesic.
Intravenous morphine: Emergency department provider chooses appropriate dose of intravenous morphine</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants Requiring Rescue Medications</title>
          <description>The percentage of patients requiring rescue IV morphine at 20 and 40 minutes</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="16"/>
                <count group_id="O2" value="16"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5"/>
                    <measurement group_id="O2" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Patient Satisfaction</title>
        <description>The proportion of patients saying, &quot;Yes&quot; to &quot;Would you have this pain medication again for similar pain?&quot;</description>
        <time_frame>60 minutes</time_frame>
        <population>1 patient in the intravenous lidocaine arm did not answer the question.</population>
        <group_list>
          <group group_id="O1">
            <title>Intravenous Lidocaine</title>
            <description>Participants will receive IV lidocaine (75 mg if &lt;50kg, 100 mg if 50 – 100 kg, and 150 mg if &gt;100 kg) over 10 minutes in a 100 mL normal saline minibag followed by a 50 minute IV lidocaine drip (75 mg if &lt;50kg, 100 mg if 50 – 100 kg, and 150 mg if &gt;100 kg) in a 100 mL normal saline minibag.
At 20 and 40 minutes, participants can elect to receive morphine 4mg IV as a rescue analgesic.
Intravenous lidocaine: Intravenous lidocaine drip over 10 minutes followed by intravenous lidocaine drip over 50 minutes</description>
          </group>
          <group group_id="O2">
            <title>Morphine</title>
            <description>ED provider will choose an appropriate dose of intravenous morphine for the patient.
At 20 and 40 minutes, participants can elect to receive morphine 4mg IV as a rescue analgesic.
Intravenous morphine: Emergency department provider chooses appropriate dose of intravenous morphine</description>
          </group>
        </group_list>
        <measure>
          <title>Patient Satisfaction</title>
          <description>The proportion of patients saying, &quot;Yes&quot; to &quot;Would you have this pain medication again for similar pain?&quot;</description>
          <population>1 patient in the intravenous lidocaine arm did not answer the question.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="15"/>
                <count group_id="O2" value="16"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="13"/>
                    <measurement group_id="O2" value="14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants Reporting Adverse Events</title>
        <description>Participants will be observed for the following adverse events and side effects: seizure, bradyarrhythmias, hyper or hypotension, perioral numbness, tinnitus, metallic taste, other, hypotension, hypoxia, nausea, vomiting, itching, or other side effects. Participants have the opportunity to report other side effects during the study</description>
        <time_frame>0-60 minutes</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Intravenous Lidocaine</title>
            <description>Participants will receive IV lidocaine (75 mg if &lt;50kg, 100 mg if 50 – 100 kg, and 150 mg if &gt;100 kg) over 10 minutes in a 100 mL normal saline minibag followed by a 50 minute IV lidocaine drip (75 mg if &lt;50kg, 100 mg if 50 – 100 kg, and 150 mg if &gt;100 kg) in a 100 mL normal saline minibag.
At 20 and 40 minutes, participants can elect to receive morphine 4mg IV as a rescue analgesic.
Intravenous lidocaine: Intravenous lidocaine drip over 10 minutes followed by intravenous lidocaine drip over 50 minutes</description>
          </group>
          <group group_id="O2">
            <title>Morphine</title>
            <description>ED provider will choose an appropriate dose of intravenous morphine for the patient.
At 20 and 40 minutes, participants can elect to receive morphine 4mg IV as a rescue analgesic.
Intravenous morphine: Emergency department provider chooses appropriate dose of intravenous morphine</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants Reporting Adverse Events</title>
          <description>Participants will be observed for the following adverse events and side effects: seizure, bradyarrhythmias, hyper or hypotension, perioral numbness, tinnitus, metallic taste, other, hypotension, hypoxia, nausea, vomiting, itching, or other side effects. Participants have the opportunity to report other side effects during the study</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="16"/>
                <count group_id="O2" value="16"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Intravenous Lidocaine</title>
          <description>Participants will receive IV lidocaine (75 mg if &lt;50kg, 100 mg if 50 – 100 kg, and 150 mg if &gt;100 kg) over 10 minutes in a 100 mL normal saline minibag followed by a 50 minute IV lidocaine drip (75 mg if &lt;50kg, 100 mg if 50 – 100 kg, and 150 mg if &gt;100 kg) in a 100 mL normal saline minibag.
At 20 and 40 minutes, participants can elect to receive morphine 4mg IV as a rescue analgesic.
Intravenous lidocaine: Intravenous lidocaine drip over 10 minutes followed by intravenous lidocaine drip over 50 minutes</description>
        </group>
        <group group_id="E2">
          <title>Morphine</title>
          <description>ED provider will choose an appropriate dose of intravenous morphine for the patient.
At 20 and 40 minutes, participants can elect to receive morphine 4mg IV as a rescue analgesic.
Intravenous morphine: Emergency department provider chooses appropriate dose of intravenous morphine</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="16"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="16"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="16"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>bradycardia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="16"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Nausea</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="16"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="16"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Pruritus</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="16"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="16"/>
              </event>
              <event>
                <sub_title>Perioral numbness</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="16"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="16"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>This study was limited by a small sample size and lack of blinding.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Andrew Herring</name_or_title>
      <organization>Alameda Health System</organization>
      <phone>510 437-8356</phone>
      <email>aherring@alamedahealthsystem.org</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

